Drug Type Molecular glue |
Synonyms- |
Target |
Action modulators |
Mechanism Ubiquitin ligase modulators(E3 ubiquitin ligase components modulators) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Preclinical | United States | 17 Sep 2025 | |
| Psoriasis | Preclinical | United States | 17 Sep 2025 |





